Banque Transatlantique Sa Actinium Pharmaceuticals, Inc. Call Options Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATNM
# of Institutions
72Shares Held
8.18MCall Options Held
51.9KPut Options Held
6.2K-
Black Rock Inc. New York, NY1.88MShares$3.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$2.58 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$1.17 Million0.0% of portfolio
-
State Street Corp Boston, MA645KShares$1.06 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA504KShares$826,6220.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $41.3M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...